OMNICELL INC (OMCL) Stock Fundamental Analysis
NASDAQ:OMCL - Nasdaq - US68213N1090 - Common Stock - Currency: USD
Taking everything into account, OMCL scores 4 out of 10 in our fundamental rating. OMCL was compared to 187 industry peers in the Health Care Equipment & Supplies industry. OMCL has an average financial health and profitability rating. OMCL has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year OMCL was profitable.
In the past year OMCL had a positive cash flow from operations.
Of the past 5 years OMCL 4 years were profitable.
Each year in the past 5 years OMCL had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 0.98%, OMCL is doing good in the industry, outperforming 73.80% of the companies in the same industry.
OMCL has a better Return On Equity (1.69%) than 74.87% of its industry peers.
OMCL has a Return On Invested Capital of 0.64%. This is in the better half of the industry: OMCL outperforms 66.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.98% | ||
| ROE | 1.69% | ||
| ROIC | 0.64% |
ROA(3y)-0.02%
ROA(5y)1.07%
ROE(3y)-0.07%
ROE(5y)1.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of OMCL (1.87%) is better than 74.33% of its industry peers.
In the last couple of years the Profit Margin of OMCL has declined.
OMCL has a Operating Margin of 1.11%. This is in the better half of the industry: OMCL outperforms 65.78% of its industry peers.
OMCL's Operating Margin has declined in the last couple of years.
OMCL has a Gross Margin of 43.24%. This is in the lower half of the industry: OMCL underperforms 63.64% of its industry peers.
In the last couple of years the Gross Margin of OMCL has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.11% | ||
| PM (TTM) | 1.87% | ||
| GM | 43.24% |
OM growth 3Y-60.62%
OM growth 5Y-43.72%
PM growth 3Y-45.27%
PM growth 5Y-30.27%
GM growth 3Y-4.46%
GM growth 5Y-2.57%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so OMCL is destroying value.
OMCL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for OMCL has been increased compared to 5 years ago.
Compared to 1 year ago, OMCL has an improved debt to assets ratio.
2.2 Solvency
OMCL has an Altman-Z score of 1.77. This is a bad value and indicates that OMCL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.77, OMCL perfoms like the industry average, outperforming 57.22% of the companies in the same industry.
OMCL has a debt to FCF ratio of 3.17. This is a good value and a sign of high solvency as OMCL would need 3.17 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 3.17, OMCL belongs to the best of the industry, outperforming 87.70% of the companies in the same industry.
A Debt/Equity ratio of 0.13 indicates that OMCL is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.13, OMCL is in line with its industry, outperforming 56.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 3.17 | ||
| Altman-Z | 1.77 |
ROIC/WACC0.09
WACC6.82%
2.3 Liquidity
OMCL has a Current Ratio of 1.38. This is a normal value and indicates that OMCL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.38, OMCL is doing worse than 79.14% of the companies in the same industry.
OMCL has a Quick Ratio of 1.23. This is a normal value and indicates that OMCL is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of OMCL (1.23) is worse than 70.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.38 | ||
| Quick Ratio | 1.23 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 24.52% over the past year.
The Earnings Per Share has been decreasing by -9.56% on average over the past years.
OMCL shows a small growth in Revenue. In the last year, the Revenue has grown by 3.00%.
OMCL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.40% yearly.
EPS 1Y (TTM)24.52%
EPS 3Y-23.52%
EPS 5Y-9.56%
EPS Q2Q%766.67%
Revenue 1Y (TTM)3%
Revenue growth 3Y-0.59%
Revenue growth 5Y4.4%
Sales Q2Q%9.55%
3.2 Future
The Earnings Per Share is expected to decrease by -1.66% on average over the next years.
OMCL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.90% yearly.
EPS Next Y-21.74%
EPS Next 2Y-4.77%
EPS Next 3Y-1.66%
EPS Next 5YN/A
Revenue Next Year2.48%
Revenue Next 2Y3.23%
Revenue Next 3Y3.76%
Revenue Next 5Y14.9%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 14.52, OMCL is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of OMCL indicates a rather cheap valuation: OMCL is cheaper than 86.63% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.54. OMCL is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 18.18, which indicates a rather expensive current valuation of OMCL.
79.68% of the companies in the same industry are more expensive than OMCL, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of OMCL to the average of the S&P500 Index (36.44), we can say OMCL is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.52 | ||
| Fwd PE | 18.18 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, OMCL is valued cheaply inside the industry as 87.70% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, OMCL is valued cheaply inside the industry as 94.65% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.21 | ||
| EV/EBITDA | 11.07 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.77%
EPS Next 3Y-1.66%
5. Dividend
5.1 Amount
OMCL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
28.03
+1.15 (+4.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners104.33%
Inst Owner Change-0.29%
Ins Owners1.78%
Ins Owner Change28.61%
Market Cap1.31B
Analysts76
Price Target45.39 (61.93%)
Short Float %4.69%
Short Ratio3.42
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.88%
Min EPS beat(2)1.42%
Max EPS beat(2)24.34%
EPS beat(4)4
Avg EPS beat(4)76.74%
Min EPS beat(4)1.42%
Max EPS beat(4)245.61%
EPS beat(8)8
Avg EPS beat(8)84.73%
EPS beat(12)11
Avg EPS beat(12)115.95%
EPS beat(16)14
Avg EPS beat(16)89.93%
Revenue beat(2)2
Avg Revenue beat(2)1.05%
Min Revenue beat(2)0.42%
Max Revenue beat(2)1.68%
Revenue beat(4)3
Avg Revenue beat(4)1.79%
Min Revenue beat(4)-1.27%
Max Revenue beat(4)6.33%
Revenue beat(8)5
Avg Revenue beat(8)1.31%
Revenue beat(12)7
Avg Revenue beat(12)0.37%
Revenue beat(16)8
Avg Revenue beat(16)0.22%
PT rev (1m)-0.74%
PT rev (3m)-16.82%
EPS NQ rev (1m)3.48%
EPS NQ rev (3m)-38.07%
EPS NY rev (1m)6.69%
EPS NY rev (3m)-26.86%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-1.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.52 | ||
| Fwd PE | 18.18 | ||
| P/S | 1.16 | ||
| P/FCF | 12.21 | ||
| P/OCF | 8.02 | ||
| P/B | 1.04 | ||
| P/tB | 4.67 | ||
| EV/EBITDA | 11.07 |
EPS(TTM)1.93
EY6.89%
EPS(NY)1.54
Fwd EY5.5%
FCF(TTM)2.3
FCFY8.19%
OCF(TTM)3.49
OCFY12.47%
SpS24.25
BVpS26.84
TBVpS6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.98% | ||
| ROE | 1.69% | ||
| ROCE | 0.81% | ||
| ROIC | 0.64% | ||
| ROICexc | 0.89% | ||
| ROICexgc | 6.88% | ||
| OM | 1.11% | ||
| PM (TTM) | 1.87% | ||
| GM | 43.24% | ||
| FCFM | 9.47% |
ROA(3y)-0.02%
ROA(5y)1.07%
ROE(3y)-0.07%
ROE(5y)1.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-30.61%
ROICexc growth 3Y-63.57%
ROICexc growth 5Y-44.11%
OM growth 3Y-60.62%
OM growth 5Y-43.72%
PM growth 3Y-45.27%
PM growth 5Y-30.27%
GM growth 3Y-4.46%
GM growth 5Y-2.57%
F-Score7
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 3.17 | ||
| Debt/EBITDA | 1.62 | ||
| Cap/Depr | 62.2% | ||
| Cap/Sales | 4.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 159.08% | ||
| Profit Quality | 507.46% | ||
| Current Ratio | 1.38 | ||
| Quick Ratio | 1.23 | ||
| Altman-Z | 1.77 |
F-Score7
WACC6.82%
ROIC/WACC0.09
Cap/Depr(3y)62.08%
Cap/Depr(5y)71.19%
Cap/Sales(3y)4.74%
Cap/Sales(5y)5.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.52%
EPS 3Y-23.52%
EPS 5Y-9.56%
EPS Q2Q%766.67%
EPS Next Y-21.74%
EPS Next 2Y-4.77%
EPS Next 3Y-1.66%
EPS Next 5YN/A
Revenue 1Y (TTM)3%
Revenue growth 3Y-0.59%
Revenue growth 5Y4.4%
Sales Q2Q%9.55%
Revenue Next Year2.48%
Revenue Next 2Y3.23%
Revenue Next 3Y3.76%
Revenue Next 5Y14.9%
EBIT growth 1Y161.35%
EBIT growth 3Y-60.85%
EBIT growth 5Y-41.24%
EBIT Next Year54.52%
EBIT Next 3Y30.55%
EBIT Next 5YN/A
FCF growth 1Y125.84%
FCF growth 3Y-8.04%
FCF growth 5Y10.13%
OCF growth 1Y53.56%
OCF growth 3Y-6.79%
OCF growth 5Y5.3%